Particle.news

Download on the App Store

Georgia May Foote Seeks NHS Approval for Vitiligo Cream After Losing Business in Fire

She is campaigning for NHS approval of the JAK-inhibitor cream Opzelure to restore her pigment

Image
Image

Overview

  • On World Vitiligo Day, Foote revealed that her white patches have spread to her face, intensifying her emotional journey
  • She first developed vitiligo in 2020 and received a definitive diagnosis in 2021 after an initial misdiagnosis delayed treatment
  • Vitiligo is an autoimmune disorder affecting roughly 1% of the global population and currently lacks a permanent cure in the UK
  • A fire at a Middleton storage unit last week destroyed all of Foote’s business assets and prompted widespread public support
  • Foote is pressing the NHS to approve Ruxolitinib (Opzelure), a JAK-inhibitor cream that has shown promise in repigmentation studies